The gut microbiota is a complex community of microorganisms, including bacteria, viruses and fungi that inhabit the gastrointestinal tract. Over the years, it has been found that the gut microbiota is not only critical for gastrointestinal health, but also involved in a variety of disease processes, including metabolic diseases, autoimmune diseases, tumors and inflammatory diseases. Inflammatory diseases, such as arthritis, Inflammatory bowel disease (IBD), are becoming a major healthcare issue worldwide. Although it has been fully accepted that the interplay between gut microbiota and inflammatory responses plays significant roles in Inflammatory diseases, the specific effects of the gut microbiota on the development of inflammatory diseases and the related mechanism deserve further attention, and the microbiota components driving the effects need to be better characterized. In addition, the agents, such as probiotics, synbiotics or herbal medicines that target the gut microbiota for the treatment of inflammatory diseases still need to be investigated.
In this Research Topic, we aim to explore the potential roles of gut microbiota and its metabolites in inflammatory diseases and the treatments that target gut microbiota for inflammatory diseases.
We encourage the exploration of the relationship between gut microbiota and inflammatory diseases, and the treatment of inflammatory diseases that target the gut microbiota. Both Original Research and Review articles are welcomed here, including, but not limited to, the following research contents:
1. Correlation analysis of gut microbiota composition and inflammatory diseases;
2. Mechanisms of gut microbiota affecting the development of inflammatory diseases;
3. Prevention and diagnosis of inflammatory diseases based on gut microbiota
4. Probiotics, synbiotics, herbal medicines and other therapies that target the gut microbiota for inflammatory diseases.
The gut microbiota is a complex community of microorganisms, including bacteria, viruses and fungi that inhabit the gastrointestinal tract. Over the years, it has been found that the gut microbiota is not only critical for gastrointestinal health, but also involved in a variety of disease processes, including metabolic diseases, autoimmune diseases, tumors and inflammatory diseases. Inflammatory diseases, such as arthritis, Inflammatory bowel disease (IBD), are becoming a major healthcare issue worldwide. Although it has been fully accepted that the interplay between gut microbiota and inflammatory responses plays significant roles in Inflammatory diseases, the specific effects of the gut microbiota on the development of inflammatory diseases and the related mechanism deserve further attention, and the microbiota components driving the effects need to be better characterized. In addition, the agents, such as probiotics, synbiotics or herbal medicines that target the gut microbiota for the treatment of inflammatory diseases still need to be investigated.
In this Research Topic, we aim to explore the potential roles of gut microbiota and its metabolites in inflammatory diseases and the treatments that target gut microbiota for inflammatory diseases.
We encourage the exploration of the relationship between gut microbiota and inflammatory diseases, and the treatment of inflammatory diseases that target the gut microbiota. Both Original Research and Review articles are welcomed here, including, but not limited to, the following research contents:
1. Correlation analysis of gut microbiota composition and inflammatory diseases;
2. Mechanisms of gut microbiota affecting the development of inflammatory diseases;
3. Prevention and diagnosis of inflammatory diseases based on gut microbiota
4. Probiotics, synbiotics, herbal medicines and other therapies that target the gut microbiota for inflammatory diseases.